BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9099848)

  • 1. Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A.
    Bontron S; Steimle V; Ucla C; Eibl MM; Mach B
    Hum Genet; 1997 Apr; 99(4):541-6. PubMed ID: 9099848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
    Steimle V; Otten LA; Zufferey M; Mach B
    Cell; 1993 Oct; 75(1):135-46. PubMed ID: 8402893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
    Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
    J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene.
    Peijnenburg A; Van den Berg R; Van Eggermond MJ; Sanal O; Vossen JM; Lennon AM; Alcaïde-Loridan C; Van den Elsen PJ
    Immunogenetics; 2000 Jan; 51(1):42-9. PubMed ID: 10663561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.
    Bradley MB; Fernandez JM; Ungers G; Diaz-Barrientos T; Steimle V; Mach B; O'Reilly R; Lee JS
    J Immunol; 1997 Aug; 159(3):1086-95. PubMed ID: 9233601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.
    Peijnenburg A; Van Eggermond MJ; Gobin SJ; Van den Berg R; Godthelp BC; Vossen JM; Van den Elsen PJ
    J Immunol; 1999 Jul; 163(2):794-801. PubMed ID: 10395672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of MHC class II gene expression in a patient with a single amino acid substitution in the class II transactivator protein CIITA.
    Quan V; Towey M; Sacks S; Kelly AP
    Immunogenetics; 1999 Oct; 49(11-12):957-63. PubMed ID: 10501838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.
    Steimle V; Siegrist CA; Mottet A; Lisowska-Grospierre B; Mach B
    Science; 1994 Jul; 265(5168):106-9. PubMed ID: 8016643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome.
    Cressman DE; Chin KC; Taxman DJ; Ting JP
    Immunity; 1999 Feb; 10(2):163-71. PubMed ID: 10072069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency.
    Dziembowska M; Fondaneche MC; Vedrenne J; Barbieri G; Wiszniewski W; Picard C; Cant AJ; Steimle V; Charron D; Alca-Loridan C; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2002 Feb; 53(10-11):821-9. PubMed ID: 11862382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines.
    Tschickardt ME; Lu Y; Jacim M; Ussery GD; Steimle V; Mach B; Blanck G
    Int J Cancer; 1995 Aug; 62(4):461-5. PubMed ID: 7635572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation in the class II trans-activator leading to a mild immunodeficiency.
    Wiszniewski W; Fondaneche MC; Le Deist F; Kanariou M; Selz F; Brousse N; Steimle V; Barbieri G; Alcaide-Loridan C; Charron D; Fischer A; Lisowska-Grospierre B
    J Immunol; 2001 Aug; 167(3):1787-94. PubMed ID: 11466404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency.
    Zhou H; Glimcher LH
    Immunity; 1995 May; 2(5):545-53. PubMed ID: 7749985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.
    Waldburger JM; Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Landmann S; Reith W
    Immunol Rev; 2000 Dec; 178():148-65. PubMed ID: 11213800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
    Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
    J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). 1993.
    Steimle V; Otten LA; Zufferey M; Mach B
    J Immunol; 2007 Jun; 178(11):6677-88. PubMed ID: 17513710
    [No Abstract]   [Full Text] [Related]  

  • 17. An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator.
    Douhan J; Lieberson R; Knoll JH; Zhou H; Glimcher LH
    J Exp Med; 1997 Jun; 185(11):1885-95. PubMed ID: 9166418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency.
    Villard J; Lisowska-Grospierre B; van den Elsen P; Fischer A; Reith W; Mach B
    N Engl J Med; 1997 Sep; 337(11):748-53. PubMed ID: 9287230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA).
    Riley JL; Westerheide SD; Price JA; Brown JA; Boss JM
    Immunity; 1995 May; 2(5):533-43. PubMed ID: 7749984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RAG cell line defines a new complementation group of MHC class II deficiency.
    Lennon A; Ottone C; Peijnenburg A; Hamon-Benais C; Colland F; Gobin S; van den Elsen P; Fellous M; Bono R; Alcaïde-Loridan C
    Immunogenetics; 1996; 43(6):352-9. PubMed ID: 8606055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.